A Role of BDNF in the Depression Pathogenesis and a Potential Target as Antidepressant: The Modulator of Stress Sensitivity “Shati/Nat8l-BDNF System” in the Dorsal Striatum
Open accessThe DOI matches its Crossref record; 164 of the 164 references it cites were found in a registry or an index.
Abstract
Depression is one of the most common mental diseases, with increasing numbers of patients globally each year. In addition, approximately 30% of patients with depression are resistant to any treatment and do not show an expected response to first-line antidepressant drugs. Therefore, novel antidepressant agents and strategies are required. Although depression is triggered by post-birth stress, while some individuals show the pathology of depression, others remain resilient. The molecular mechanisms underlying stress sensitivity remain unknown. Brain-derived neurotrophic factor (BDNF) has both pro- and anti-depressant effects, dependent on brain region. Considering the strong region-specific contribution of BDNF to depression pathogenesis, the regulation of BDNF in the whole brain is not a beneficial strategy for the treatment of depression. We reviewed a novel finding of BDNF function in the dorsal striatum, which induces vulnerability to social stress, in addition to recent research progress regarding the brain regional functions of BDNF, including the prefrontal cortex, hippocampus, and nucleus accumbens. Striatal BDNF is regulated by Shati/Nat8l, an N-acetyltransferase through epigenetic regulation. Targeting of Shati/Nat8l would allow BDNF to be striatum-specifically regulated, and the striatal Shati/Nat8l-BDNF pathway could be a promising novel therapeutic agent for the treatment of depression by modulating sensitivity to stress.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“its expression is significantly reduced in brain areas such as the prefrontal cortex and hippocampus in patients with depression.”
From Variations in BDNF and Their Role in the Neurotrophic Antidepressant Mechanisms of Ketamine and Esketamine: A Review (2024) · cites this paper as [4]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643 · cited 1×
“Generally, these drugs require long periods before the effects are seen [11] and do not show high response rates in approximately 30% of patients with depression, who are resistant to treatment [12,13].”
BackgroundStress and the brain: from adaptation to disease
de Kloet, E. R., Joëls, M., & Holsboer, F. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1683 · Cited by 4,621
Egan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00035-7 · Cited by 3,888 · cited 1×
“The presence of the BDNF Val66Met polymorphism impairs BDNF release [91] and the maturation of BDNF from proBDNF in the hippocampus [92].”
BackgroundTrivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879 · cited 1×
“Generally, these drugs require long periods before the effects are seen [11] and do not show high response rates in approximately 30% of patients with depression, who are resistant to treatment [12,13].”
BackgroundA randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766 · cited 1×
“sustained antidepressant effects, even in patients with treatment resistance [162].”
BackgroundA Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375 · cited 4×
“Hippocampus Human [93,94,101,108] pro-depressant increasing Animal [30,102–106,109]”
BackgroundInfluentialKrishnan, V., Han, M.-H., Graham, D. L., Berton, O., Renthal, W., Russo, S. J., LaPlant, Q., Graham, A., Lutter, M., Lagace, D. C., et al. (2007) · Cell · doi:10.1016/j.cell.2007.09.018 · Cited by 2,307 · cited 4×
“Mesolimbic pathway Human [111] anti-depressant decreasing Animal [29,58,110,112,113,122]”
BackgroundInfluentialCross-national epidemiology of DSM-IV major depressive episode
Bromet, E., Andrade, L. H., Hwang, I., Sampson, N. A., Alonso, J., de Girolamo, G., de Graaf, R., Demyttenaere, K., Hu, C., Iwata, N., et al. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-90 · Cited by 2,221 · cited 1×
“The prevalence of depression in lifetime reached 15–18% [3], meaning that one in five people were affected by the condition in their lifetime.”
BackgroundEssential role of BDNF in the mesolimbic dopamine pathway in social defeat stress
Berton, O., McClung, C. A., DiLeone, R. J., Krishnan, V., Renthal, W., Russo, S. J., Graham, D., Tsankova, N. M., Bolanos, C. A., Rios, M., et al. (2006) · Science · doi:10.1126/science.1120972 · Cited by 2,129 · cited 7×
“The role of BDNF in the central nervous system (CNS) in depression may depend on the circuit and region, with both antidepressant and antidepressant effects [29,30].”
BackgroundResultInfluentialThe mesolimbic dopamine reward circuit in depression
Nestler, E. J., & Carlezon, W. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.018 · Cited by 2,059 · cited 3×
“Mesolimbic pathway Human [111] anti-depressant decreasing Animal [29,58,110,112,113,122]”
BackgroundPurification of a new neurotrophic factor from mammalian brain.
Barde, Y. A., Edgar, D., & Thoenen, H. (1982) · The EMBO Journal · doi:10.1002/j.1460-2075.1982.tb01207.x · Cited by 1,822 · cited 1×
“In 1982, BDNF was discovered and purified from the pig brain as the second member of the neurotrophin family that also includes neurotrophin-3 and neurotrophin-4 and which facilitates neuronal survival in the dorsal root ganglion [32].”
BackgroundSustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action
Tsankova, N. M., Berton, O., Renthal, W., Kumar, A., Neve, R. L., & Nestler, E. J. (2006) · Nature Neuroscience · doi:10.1038/nn1659 · Cited by 1,780 · cited 2×
“These findings are consistent with those of a clinical study in which patients with depression also showed reduced BDNF IV expression in the hippocampus and frontal cortex, as well as in animal models of depression [46,47].”
BackgroundResultSynaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
Duman, R. S., Aghajanian, G. K., Sanacora, G., & Krystal, J. H. (2016) · Nature Medicine · doi:10.1038/nm.4050 · Cited by 1,750 · cited 2×
“Preclinical studies have revealed that ketamine treatment rapidly induced glutamate release in the PFC via regulation of synaptic plasticity [73].”
BackgroundHippocampal Volume Reduction in Major Depression
Bremner, J. D., Narayan, M., Anderson, E. R., Staib, L. H., Miller, H. L., & Charney, D. S. (2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.115 · Cited by 1,670 · cited 1×
“Structural alterations, including decreased hippocampal and PFC volumes, have been reported in patients with depression [99,100].”
BackgroundBrain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression
Shirayama, Y., Chen, A. C.-H., Nakagawa, S., Russell, D. S., & Duman, R. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03251.2002 · Cited by 1,654 · cited 1×
“Similarly, microinfusion of BDNF into the hippocampus restored depressionlike behaviors induced by chronic stress [106].”
BackgroundA standardized protocol for repeated social defeat stress in mice
Golden, S. A., Covington, H. E., Berton, O., & Russo, S. J. (2011) · Nature Protocols · doi:10.1038/nprot.2011.361 · Cited by 1,581 · cited 1×
“Rodents exposed to repeated social-defeat stress, which has been used as a major stressful event, can also be classified as either stress-susceptible (showing depression-like behaviors) or resilient (lack of depression-like behaviors) [26,27] However, the underlying molecular mechanisms that contribute to resilience a…”
BackgroundRisk factors for suicide in individuals with depression: a systematic review
Hawton, K., Casañas i Comabella, C., Haw, C., & Saunders, K. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.01.004 · Cited by 1,469 · cited 1×
“Furthermore, depression is strongly associated with a risk of low energy and the presence of suicidal ideation [8,9].”
BackgroundThe Role of the Dorsal Striatum in Reward and Decision-Making: Figure 1.
Balleine, B. W., Delgado, M. R., & Hikosaka, O. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1554-07.2007 · Cited by 1,390 · cited 1×
“Initiation and choice of action and motivational and emotional behaviors are regulated by specific dorsal–striatal circuits [129].”
BackgroundRapid regulation of depression-related behaviours by control of midbrain dopamine neurons
Chaudhury, D., Walsh, J. J., Friedman, A. K., Juarez, B., Ku, S. M., Koo, J. W., Ferguson, D., Tsai, H.-C., Pomeranz, L., Christoffel, D. J., et al. (2013) · Nature · doi:10.1038/nature11713 · Cited by 1,156 · cited 2×
“In the VTA-to-PFC circuits, decreased and increased firing activities were observed in the susceptible and resilient groups, respectively [121], suggesting a region-specific function of DA neurons in depression pathogenesis.”
BackgroundMice lacking brain-derived neurotrophic factor develop with sensory deficits
Ernfors, P., Lee, K.-F., & Jaenisch, R. (1994) · Nature · doi:10.1038/368147a0 · Cited by 1,067 · cited 1×
“Very few BDNF knockout mice reach adulthood; those that do so show severe sensory impairment [35].”
BackgroundSuicidality in Pediatric Patients Treated With Antidepressant Drugs
Hammad, T. A., Laughren, T., & Racoosin, J. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.3.332 · Cited by 1,054 · cited 1×
“the United States Food and Drug Administration (USFDA) warned of treatment-associated suicidality as an adverse event associated with antidepressant treatment [15].”
BackgroundDuman, R. S., Sanacora, G., & Krystal, J. H. (2019) · Neuron · doi:10.1016/j.neuron.2019.03.013 · Cited by 1,026 · cited 1×
“Many studies have focused on the PFC as the region displaying altered function, potentially triggered by altered glutamatergic and gamma-aminobutyric acid (GABA) transmission [82].”
BackgroundColucci-D’Amato, L., Speranza, L., & Volpicelli, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207777 · Cited by 991 · cited 4×
“Shati/Nat8l and NAA have various functions in the CNS.”
BackgroundInfluentialHeim, C., & Binder, E. B. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2011.10.032 · Cited by 986 · cited 1×
“This hypothesis is composed of two combined factors of genetic and environmental elements in the development of a psychiatric illness, including depression [138,139].”
BackgroundHiser, J., & Koenigs, M. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.10.030 · Cited by 972 · cited 1×
“The PFC plays an important role in learning, memory, and decision-making processes [59,60].”
BackgroundAdult brain neurogenesis and psychiatry: a novel theory of depression
Jacobs, B. L., van Praag, H., & Gage, F. H. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000712 · Cited by 964 · cited 1×
“While impaired hippocampal neurogenesis can lead to depression [97], BDNF upregulation stimulates hippocampal neurogenesis, followed by an induced antidepressant effect [98].”
BackgroundBDNF - a key transducer of antidepressant effects
Björkholm, C., & Monteggia, L. M. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.034 · Cited by 958 · cited 1×
“BDNF is the most abundantly expressed member of the neurotrophin family in the CNS [33] and it plays an important role in neuronal development, morphology, and synaptic formation and function in the whole brain [34].”
BackgroundLevi‐Montalcini, R., & Hamburger, V. (1951) · Journal of Experimental Zoology · doi:10.1002/jez.1401160206 · Cited by 955 · cited 1×
“Nerve growth factor (NGF) was identified in the early 1950s as the first member of the neurotrophin family, which induced neuron growth and survival promotion [31].”
BackgroundBDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders
Mattson, M. P., Maudsley, S., & Martin, B. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.08.001 · Cited by 942 · cited 1×
“A loss of serotonergic neurons was observed in a mouse model of depression due to reduced BDNF in the hippocampus, since these neurons grow and survive via BDNF-TrkB signaling cascades [107].”
BackgroundRibeiro, J. D., Huang, X., Fox, K. R., & Franklin, J. C. (2018) · British Journal of Psychiatry · doi:10.1192/bjp.2018.27 · Cited by 894 · cited 1×
“Furthermore, depression is strongly associated with a risk of low energy and the presence of suicidal ideation [8,9].”
BackgroundPezawas, L., Verchinski, B. A., Mattay, V. S., Callicott, J. H., Kolachana, B. S., Straub, R. E., Egan, M. F., Meyer-Lindenberg, A., & Weinberger, D. R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2680-04.2004 · Cited by 890 · cited 4×
“Hippocampus Human [93,94,101,108] pro-depressant increasing Animal [30,102–106,109]”
BackgroundInfluentialDwivedi, Y., Rizavi, H. S., Conley, R. R., Roberts, R. C., Tamminga, C. A., & Pandey, G. N. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.8.804 · Cited by 875 · cited 1×
“Clinical studies of postmortem brains have reported decreased BDNF and TrkB levels in the PFC of subjects who committed suicide [69,70] and patients with depression [71,72].”
BackgroundChronic Stress Causes Frontostriatal Reorganization and Affects Decision-Making
Dias-Ferreira, E., Sousa, J. C., Melo, I., Morgado, P., Mesquita, A. R., Cerqueira, J. J., Costa, R. M., & Sousa, N. (2009) · Science · doi:10.1126/science.1171203 · Cited by 858 · cited 1×
“The reported hypertrophy of the dorsal striatum in response to chronic stress is supported by our results showing increased BDNF in the dorsal striatum by RSDS, as BDNF is required for neurogenesis [137].”
ResultMultiple promoters direct tissue-specific expression of the rat BDNF gene
Timmusk, T., Palm, K., Metsis, M., Reintam, T., Paalme, V., Saarma, M., & Persson, H. (1993) · Neuron · doi:10.1016/0896-6273(93)90335-o · Cited by 858 · cited 1×
“The contribution of the region-specific BDNF effect is attributed to the distinct BDNF transcripts [44].”
BackgroundSoppet, D., Escandon, E., Maragos, J., Middlemas, D. S., Raid, S. W., Blair, J., Burton, L. E., Stanton, B. R., Kaplan, D. R., Hunter, T., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90396-g · Cited by 820 · cited 1×
“TrkB receptors exist both pre- and post- synapse [38].”
BackgroundThe Link between Depression and Chronic Pain: Neural Mechanisms in the Brain
Sheng, J., Liu, S., Wang, Y., Cui, R., & Zhang, X. (2017) · Neural Plasticity · doi:10.1155/2017/9724371 · Cited by 775
Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model
Price, R. B., & Duman, R. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0615-x · Cited by 739 · cited 1×
“The symptoms of depression include deficits in cognitive function [4,5], loss of motivation [6], and anhedonia [7].”
BackgroundPruunsild, P., Kazantseva, A., Aid, T., Palm, K., & Timmusk, T. (2007) · Genomics · doi:10.1016/j.ygeno.2007.05.004 · Cited by 699 · cited 1×
“The BDNF gene has nine promoters, each of which drives the expression of distinct BDNF transcripts [42,43].”
BackgroundMonroe, S. M., & Harkness, K. L. (2005) · Psychological Review · doi:10.1037/0033-295x.112.2.417 · Cited by 693
The Role of Neural Plasticity in Depression: From Hippocampus to Prefrontal Cortex
Liu, W., Ge, T., Leng, Y., Pan, Z., Fan, J., Yang, W., & Cui, R. (2017) · Neural Plasticity · doi:10.1155/2017/6871089 · Cited by 640 · cited 1×
“Neuronal plasticity in the hippocampus is altered by stress, which increases the risk of depression [87].”
BackgroundRossi, C., Angelucci, A., Costantin, L., Braschi, C., Mazzantini, M., Babbini, F., Fabbri, M. E., Tessarollo, L., Maffei, L., Berardi, N., et al. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05059.x · Cited by 619 · cited 1×
“While impaired hippocampal neurogenesis can lead to depression [97], BDNF upregulation stimulates hippocampal neurogenesis, followed by an induced antidepressant effect [98].”
BackgroundHippocampal neurogenesis confers stress resilience by inhibiting the ventral dentate gyrus
Anacker, C., Luna, V. M., Stevens, G. S., Millette, A., Shores, R., Jimenez, J. C., Chen, B., & Hen, R. (2018) · Nature · doi:10.1038/s41586-018-0262-4 · Cited by 605 · cited 1×
“Neurogenesis in the hippocampus contributes to antidepressant effects [95,96].”
BackgroundKarege, F., Vaudan, G., Schwald, M., Perroud, N., & La Harpe, R. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.12.020 · Cited by 600 · cited 1×
“Clinical studies of postmortem brains have reported decreased BDNF and TrkB levels in the PFC of subjects who committed suicide [69,70] and patients with depression [71,72].”
BackgroundThe mouse cortico-striatal projectome
Hintiryan, H., Foster, N. N., Bowman, I., Bay, M., Song, M. Y., Gou, L., Yamashita, S., Bienkowski, M. S., Zingg, B., Zhu, M., et al. (2016) · Nature Neuroscience · doi:10.1038/nn.4332 · Cited by 563 · cited 1×
“mainly receives direct excitatory input from the primary motor and sensory cortices [125], suggesting the involvement of the striatum and motor function.”
BackgroundThe Aging Hippocampus: Interactions between Exercise, Depression, and BDNF
Erickson, K. I., Miller, D. L., & Roecklein, K. A. (2012) · The Neuroscientist · doi:10.1177/1073858410397054 · Cited by 548
Gatt, J. M., Nemeroff, C. B., Dobson-Stone, C., Paul, R. H., Bryant, R. A., Schofield, P. R., Gordon, E., Kemp, A. H., & Williams, L. M. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.143 · Cited by 525
The Role of PI3K/Akt and ERK in Neurodegenerative Disorders
Rai, S. N., Dilnashin, H., Birla, H., Singh, S. S., Zahra, W., Rathore, A. S., Singh, B. K., & Singh, S. P. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-0003-y · Cited by 478
Stress, epigenetics and depression: A systematic review
Park, C., Rosenblat, J. D., Brietzke, E., Pan, Z., Lee, Y., Cao, B., Zuckerman, H., Kalantarova, A., & McIntyre, R. S. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.04.010 · Cited by 465 · cited 1×
“Stress is closely related to the pathogenesis of depression [16].”
BackgroundTaliaz, D., Stall, N., Dar, D. E., & Zangen, A. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.67 · Cited by 454 · cited 1×
“In addition, hippocampal BDNF knockdown mice, microinjected with lentiviral vectors, showed reduced neurogenesis and depression-like behaviors [104].”
BackgroundBDNF and Hippocampal Synaptic Plasticity
Leal, G., Bramham, C. R., & Duarte, C. B. (2017) · Vitamins and Hormones · doi:10.1016/bs.vh.2016.10.004 · Cited by 425 · cited 1×
“BDNF also affects learning and memory, as well as neuronal survival, through the regulation of synaptic plasticity [36,37].”
BackgroundEisch, A. J., Bolaños, C. A., de Wit, J., Simonak, R. D., Pudiak, C. M., Barrot, M., Verhaagen, J., & Nestler, E. J. (2003) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.08.003 · Cited by 420 · cited 4×
“Mesolimbic pathway Human [111] anti-depressant decreasing Animal [29,58,110,112,113,122]”
BackgroundResultInfluentialPhillips, J. L., Norris, S., Talbot, J., Birmingham, M., Hatchard, T., Ortiz, A., Owoeye, O., Batten, L. A., & Blier, P. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.18070834 · Cited by 418 · cited 1×
“A rapid-acting antidepressant agent, ketamine, an N-methyl-D-aspartate receptor (NMDAR) antagonist, also transiently activates the PFC neuron [67], with an antidepressant effect in patients with depression, even those with treatment resistance [68].”
BackgroundIs it time to reassess the BDNF hypothesis of depression?
Groves, J. O. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002075 · Cited by 404 · cited 1×
“As alterations in BDNF levels directly affect the pathogenesis of depression, the regulation of these levels might lead to the development of treatments for depression [28].”
BackgroundLiu, R.-J., Lee, F. S., Li, X.-Y., Bambico, F., Duman, R. S., & Aghajanian, G. K. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.09.030 · Cited by 403 · cited 1×
“BDNF mutant knock-in mice exhibited decreased length and branching of apical dendrites in PFC neurons and vulnerability to chronic stress [78,79].”
BackgroundFrodl, T., Schüle, C., Schmitt, G., Born, C., Baghai, T., Zill, P., Bottlender, R., Rupprecht, R., Bondy, B., Reiser, M., et al. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.4.410 · Cited by 394 · cited 4×
“Hippocampus Human [93,94,101,108] pro-depressant increasing Animal [30,102–106,109]”
BackgroundInfluentialSlavich, G. M., & Sacher, J. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05326-9 · Cited by 383
BDNF release is required for the behavioral actions of ketamine
Lepack, A. E., Fuchikami, M., Dwyer, J. M., Banasr, M., & Duman, R. S. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu033 · Cited by 368 · cited 1×
“Increased glutamate release then stimulates postsynaptic AMPARs, and L-type voltage-dependent calcium channels are depolarized and activated, followed by BDNF [84,85].”
BackgroundHare, B. D., & Duman, R. S. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0685-9 · Cited by 366 · cited 1×
“All of these treatments normalize neuronal activity in the PFC and have been shown to have antidepressant effects [66].”
BackgroundMotivation and cognitive control in depression
Grahek, I., Shenhav, A., Musslick, S., Krebs, R. M., & Koster, E. H. W. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.04.011 · Cited by 348
Neale, J. H., Bzdega, T., & Wroblewska, B. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750443.x · Cited by 341
Seroogy, K. B., Lundgren, K. H., Tran, T. M. D., Guthrie, K. M., Isackson, P. J., & Gall, C. M. (1994) · Journal of Comparative Neurology · doi:10.1002/cne.903420302 · Cited by 294 · cited 1×
“BDNF and TrkB are expressed in the mesolimbic dopamine (DA) circuit, which projects from the VTA to the NAc [114,115].”
BackgroundZhang, J.-C., Wu, J., Fujita, Y., Yao, W., Ren, Q., Yang, C., Li, S.-X., Shirayama, Y., & Hashimoto, K. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu077 · Cited by 289
Wohleb, E. S., Terwilliger, R., Duman, C. H., & Duman, R. S. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.05.026 · Cited by 288 · cited 1×
“The rodents exhibited depression-like behavior due to these chronic stresses, as well as decreased numbers of spines and branches and length of dendrites in the PFC [74,75].”
BackgroundYu, H., Wang, D.-D., Wang, Y., Liu, T., Lee, F. S., & Chen, Z.-Y. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.5048-11.2012 · Cited by 275 · cited 1×
“BDNF mutant knock-in mice exhibited decreased length and branching of apical dendrites in PFC neurons and vulnerability to chronic stress [78,79].”
BackgroundTripp, A., Oh, H., Guilloux, J.-P., Martinowich, K., Lewis, D. A., & Sibille, E. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12020248 · Cited by 273 · cited 1×
“Clinical studies of postmortem brains have reported decreased BDNF and TrkB levels in the PFC of subjects who committed suicide [69,70] and patients with depression [71,72].”
BackgroundSpine synapse remodeling in the pathophysiology and treatment of depression
Duman, C. H., & Duman, R. S. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.01.022 · Cited by 257 · cited 1×
“The rodents exhibited depression-like behavior due to these chronic stresses, as well as decreased numbers of spines and branches and length of dendrites in the PFC [74,75].”
BackgroundLi, M., Li, C., Yu, H., Cai, X., Shen, X., Sun, X., Wang, J., Zhang, Y., & Wang, C. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0964-9 · Cited by 239 · cited 1×
“BDNF shows an antidepressant function in the PFC [54,55] and hippocampus [56,57] and a pro-depressant function in the BDNF in the mesolimbic dopamine (DA) circuit, originating in ventral tegmental area (VTA) DA neurons that project to the NAc [58].”
BackgroundRepeated stress increases catalytic TrkB mRNA in rat hippocampus
Nibuya, M., Takahashi, M., Russell, D. S., & Duman, R. S. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00335-3 · Cited by 236 · cited 1×
“Similar results were also observed in rodent experiments [102].”
ResultWook Koo, J., Labonté, B., Engmann, O., Calipari, E. S., Juarez, B., Lorsch, Z., Walsh, J. J., Friedman, A. K., Yorgason, J. T., Han, M.-H., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.12.009 · Cited by 231 · cited 5×
“Brain region Speceie Trials Effect to DepressionPathogenesis Alteration of Expression Levels in Depression Individuals PFC Human [69–72] pro-depressant increasing Animal [76–81] Hippocampus Human [93,94,101,108] pro-depressant increasing Animal [30,102–106,109] Mesolimbic pathway Human [111] anti-depressant decreasing…”
BackgroundInfluentialChiaruttini, C., Vicario, A., Li, Z., Baj, G., Braiuca, P., Wu, Y., Lee, F. S., Gardossi, L., Baraban, J. M., & Tongiorgi, E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902833106 · Cited by 217 · cited 1×
“The presence of the BDNF Val66Met polymorphism impairs BDNF release [91] and the maturation of BDNF from proBDNF in the hippocampus [92].”
BackgroundO’Leary, O. F., & Cryan, J. F. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.09.011 · Cited by 212 · cited 1×
“The hippocampus controls memory and learning and emotional processing and is susceptible to the effects of stress [86].”
BackgroundtDCS for the treatment of depression: a comprehensive review
Palm, U., Hasan, A., Strube, W., & Padberg, F. (2016) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-016-0674-9 · Cited by 207
Pearson-Leary, J., Zhao, C., Bittinger, K., Eacret, D., Luz, S., Vigderman, A. S., Dayanim, G., & Bhatnagar, S. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0380-x · Cited by 206
Nonomura, S., Nishizawa, K., Sakai, Y., Kawaguchi, Y., Kato, S., Uchigashima, M., Watanabe, M., Yamanaka, K., Enomoto, K., Chiken, S., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.08.002 · Cited by 202 · cited 1×
“Lesions in the dorsal striatum affect the establishment of habitual behaviors [130] and inactivation of the dorsal striatum weakens the reward system and induces goal-directed action even in the absence of a reward [131,132].”
Backgroundde Pins, B., Cifuentes-Díaz, C., Thamila Farah, A., López-Molina, L., Montalban, E., Sancho-Balsells, A., López, A., Ginés, S., Delgado-García, J. M., Alberch, J., et al. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.2121-18.2019 · Cited by 202
How Electroconvulsive Therapy Works?: Understanding the Neurobiological Mechanisms
Singh, A., & Kar, S. K. (2017) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2017.15.3.210 · Cited by 195 · cited 1×
“The methods for the treatment of depression treatment include electrical stimulation, including transcranial direct-current stimulation (tDCS) [61] and electroconvulsive therapy (ECT) [62], or magnetic stimulation including magnetic seizure therapy (MST) [63] and repetitive transcranial magnetic stimulation (rTMS) [64…”
MethodNeurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine
Deyama, S., & Duman, R. S. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.172837 · Cited by 186 · cited 2×
“The acute antidepressant effect of ketamine has also been reported to be involved in the PFC [83].”
BackgroundAssociation of BDNF Val66Met Polymorphism and Brain BDNF Levels with Major Depression and Suicide
Youssef, M. M., Underwood, M. D., Huang, Y.-Y., Hsiung, S.-C., Liu, Y., Simpson, N. R., Bakalian, M. J., Rosoklija, G. B., Dwork, A. J., Arango, V., et al. (2018) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy008 · Cited by 183
Anhedonia in depression and schizophrenia: A transdiagnostic challenge
Lambert, C. M., Silva, S. D., Ceniti, A. K., Rizvi, S. J., Foussias, G., & Kennedy, S. H. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12854 · Cited by 182 · cited 1×
“The symptoms of depression include deficits in cognitive function [4,5], loss of motivation [6], and anhedonia [7].”
BackgroundDeep brain stimulation targets for treating depression
Drobisz, D., & Damborská, A. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.11.004 · Cited by 179 · cited 1×
“Deep brain stimulation (DBS) also enables the invasive region-specific regulation of neuronal activity using implanted electrodes [65].”
MethodHuman Development: Biological and Genetic Processes
Gottesman, I. I., & Hanson, D. R. (2005) · Annual Review of Psychology · doi:10.1146/annurev.psych.56.091103.070208 · Cited by 176 · cited 1×
“This hypothesis is composed of two combined factors of genetic and environmental elements in the development of a psychiatric illness, including depression [138,139].”
BackgroundRith-Najarian, L. R., Boustani, M. M., & Chorpita, B. F. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.06.035 · Cited by 176
Tadić, A., Müller-Engling, L., Schlicht, K. F., Kotsiari, A., Dreimüller, N., Kleimann, A., Bleich, S., Lieb, K., & Frieling, H. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.58 · Cited by 175 · cited 1×
“These findings are consistent with those of a clinical study in which patients with depression also showed reduced BDNF IV expression in the hippocampus and frontal cortex, as well as in animal models of depression [46,47].”
ResultFukumoto, K., Iijima, M., & Chaki, S. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.233 · Cited by 174 · cited 1×
“The effect of R-ketamine was mediated by the activation of serotoninergic systems in the DRN through the projection from the PFC via AMPA receptor stimulation in the PFC [163].”
BackgroundLepack, A. E., Bang, E., Lee, B., Dwyer, J. M., & Duman, R. S. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.09.011 · Cited by 174 · cited 1×
“Increased glutamate release then stimulates postsynaptic AMPARs, and L-type voltage-dependent calcium channels are depolarized and activated, followed by BDNF [84,85].”
BackgroundDNA methylation and the preservation of cell identity
Bogdanović, O., & Lister, R. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.06.007 · Cited by 167 · cited 1×
“DNA methylation is also a major epigenetic modification that regulates gene expression [158].”
BackgroundRisio, L. D., Borgi, M., Pettorruso, M., Miuli, A., Ottomana, A. M., Sociali, A., Martinotti, G., Nicolò, G., Macrì, S., Giannantonio, M. D., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-01055-2 · Cited by 167 · cited 1×
“The methods for the treatment of depression treatment include electrical stimulation, including transcranial direct-current stimulation (tDCS) [61] and electroconvulsive therapy (ECT) [62], or magnetic stimulation including magnetic seizure therapy (MST) [63] and repetitive transcranial magnetic stimulation (rTMS) [64…”
MethodExercise, antidepressant treatment, and BDNF mRNA expression in the aging brain
Garza, A. A., Ha, T., Garcia, C., Chen, M. J., & Russo‐Neustadt, A. A. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2003.10.020 · Cited by 165 · cited 1×
“Treatment with an antidepressant increased BDNF expression and restored the impairments of the dendritic spine [105].”
BackgroundBerhow, M. T., Russell, D. S., Terwilliger, R. Z., Beitner-Johnson, D., Self, D. W., Lindsay, R. M., & Nestler, E. J. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00207-y · Cited by 164 · cited 1×
“This mesolimbic dopaminergic system was first considered to contribute to drug addiction [116].”
BackgroundKeller, M. B., Gelenberg, A. J., Hirschfeld, R. M. A., Rush, A. J., Thase, M. E., Kocsis, J. H., Markowitz, J. C., Fawcett, J. A., Koran, L. M., Klein, D. N., et al. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n1107 · Cited by 161 · cited 1×
“Generally, these drugs require long periods before the effects are seen [11] and do not show high response rates in approximately 30% of patients with depression, who are resistant to treatment [12,13].”
BackgroundJiang, H., Chen, S., Li, C., Lu, N., Yue, Y., Yin, Y., Zhang, Y., Zhi, X., Zhang, D., & Yuan, Y. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.43 · Cited by 148
Antidepressant-Induced Activation in Children and Adolescents: Risk, Recognition and Management
Luft, M. J., Lamy, M., DelBello, M. P., McNamara, R. K., & Strawn, J. R. (2018) · Current problems in pediatric and adolescent health care · doi:10.1016/j.cppeds.2017.12.001 · Cited by 145 · cited 1×
“Furthermore, their side effect occurs frequently in depression patients with antidepressant treatment [14].”
BackgroundBrain-derived neurotrophic factor and mental disorders
Lin, C.-C., & Huang, T.-L. (2020) · Biomedical Journal · doi:10.1016/j.bj.2020.01.001 · Cited by 143 · cited 1×
“The BDNF gene has nine promoters, each of which drives the expression of distinct BDNF transcripts [42,43].”
BackgroundSub-second Dopamine and Serotonin Signaling in Human Striatum during Perceptual Decision-Making
Bang, D., Kishida, K. T., Lohrenz, T. M., White, J. P., Laxton, A. W., Tatter, S. B., Fleming, S. M., & Montague, P. R. (2020) · Neuron · doi:10.1016/j.neuron.2020.09.015 · Cited by 142
Numan, S., & Seroogy, K. B. (1999) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19990118)403:3<295::aid-cne2>3.0.co;2-l · Cited by 141 · cited 1×
“BDNF and TrkB are expressed in the mesolimbic dopamine (DA) circuit, which projects from the VTA to the NAc [114,115].”
BackgroundSachs, B. D., Ni, J. R., & Caron, M. G. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1416866112 · Cited by 133 · cited 1×
“The hereditary reduction of serotonin in the brain induced vulnerability to social stress in mice [155] and the replenishment of serotonin by SSRI is used as the first-line treatment for depression.”
MethodVGF function in depression and antidepressant efficacy
Jiang, C. S., Lin, W.-J., Sadahiro, M., Labonté, B., Ménard, C., Pfau, M. L., Tamminga, C. A., Turecki, G., Nestler, E. J., Russo, S. J., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.233 · Cited by 130 · cited 1×
“The role of BDNF in the central nervous system (CNS) in depression may depend on the circuit and region, with both antidepressant and antidepressant effects [29,30].”
BackgroundStriatum on the anxiety map: Small detours into adolescence
Lago, T., Davis, A., Grillon, C., & Ernst, M. (2017) · Brain Research · doi:10.1016/j.brainres.2016.06.006 · Cited by 124 · cited 2×
“Many studies have shown that networks control the functions of emotional behaviors, motivation, and negative decision-making with other brain regions [133,154].”
BackgroundSupekar, K., Kochalka, J., Schaer, M., Wakeman, H., Qin, S., Padmanabhan, A., & Menon, V. (2018) · Brain · doi:10.1093/brain/awy191 · Cited by 121 · cited 1×
“Recent studies have provided evidence of an association between the mesolimbic dopaminergic system and motivation- and mood-related behaviors, including social interaction [117,118].”
BackgroundAriyannur, P. S., Moffett, J. R., Manickam, P., Pattabiraman, N., Arun, P., Nitta, A., Nabeshima, T., Madhavarao, C. N., & Namboodiri, A. M. A. (2010) · Brain Research · doi:10.1016/j.brainres.2010.04.008 · Cited by 116 · cited 2×
“Shati/Nat8l was later recognized to have N-acetyl transfer activity and is a protein that synthesizes N-acetylaspartate (NAA) fro acetyl-CoA and aspartate [141].”
BackgroundSelf-citationSeo, M. K., Ly, N. N., Lee, C. H., Cho, H. Y., Choi, C. M., Nhu, L. H., Lee, J. G., Lee, B. J., Kim, G.-M., Yoon, B. J., et al. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.02.009 · Cited by 116 · cited 1×
“The promoter of BDNF IV is the most well-characterized promoter that responds to stress in depression pathogenesis, as rodent models of depression exposed to social-defeat stress showed decreased mRNA levels of total BDNF and BDNF IV but neither BDNF transcripts [45] in response to restraint stress.”
BackgroundRole of Mesolimbic Brain-Derived Neurotrophic Factor in Depression
Koo, J. W., Chaudhury, D., Han, M.-H., & Nestler, E. J. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.05.020 · Cited by 112 · cited 5×
“Brain region Speceie Trials Effect to DepressionPathogenesis Alteration of Expression Levels in Depression Individuals PFC Human [69–72] pro-depressant increasing Animal [76–81] Hippocampus Human [93,94,101,108] pro-depressant increasing Animal [30,102–106,109] Mesolimbic pathway Human [111] anti-depressant decreasing…”
BackgroundInfluentialAbdallah, C. G., Averill, C. L., Salas, R., Averill, L. A., Baldwin, P. R., Krystal, J. H., Mathew, S. J., & Mathalon, D. H. (2017) · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2017.04.006 · Cited by 111 · cited 1×
“A rapid-acting antidepressant agent, ketamine, an N-methyl-D-aspartate receptor (NMDAR) antagonist, also transiently activates the PFC neuron [67], with an antidepressant effect in patients with depression, even those with treatment resistance [68].”
BackgroundShinohara, R., Taniguchi, M., Ehrlich, A. T., Yokogawa, K., Deguchi, Y., Chérasse, Y., Lazarus, M., Urade, Y., Ogawa, A., Kitaoka, S., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.177 · Cited by 110 · cited 1×
“Rodents exposed to repeated social-defeat stress, which has been used as a major stressful event, can also be classified as either stress-susceptible (showing depression-like behaviors) or resilient (lack of depression-like behaviors) [26,27] However, the underlying molecular mechanisms that contribute to resilience a…”
BackgroundRole of the Brain's Reward Circuitry in Depression
Nestler, E. J. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.07.003 · Cited by 108 · cited 1×
“Considering the loss of happiness and motivation as the main symptoms in patients with depression [119], it is quite likely that abnormalities of the mesolimbic DA system are involved in depressive-like outcomes [58,120].”
BackgroundThe neurobiology of the stress-resistant brain
Fleshner, M., Maier, S. F., Lyons, D. M., & Raskind, M. A. (2011) · Stress · doi:10.3109/10253890.2011.596865 · Cited by 98
Neale, J. H., Olszewski, R. T., Zuo, D., Janczura, K. J., Profaci, C. P., Lavin, K. M., Madore, J. C., & Bzdega, T. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07338.x · Cited by 97 · cited 1×
“NAAG is widely present in the brains of mammals [143] and functions as a highly selective neurotransmitter for group II metabotropic glutamate receptor 3 (mGluR3) [144].”
BackgroundMagnetic seizure therapy (MST) for major depressive disorder
Daskalakis, Z. J., Dimitrova, J., McClintock, S. M., Sun, Y., Voineskos, D., Rajji, T. K., Goldbloom, D. S., Wong, A. H. C., Knyahnytska, Y., Mulsant, B. H., et al. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-019-0515-4 · Cited by 92 · cited 1×
“The methods for the treatment of depression treatment include electrical stimulation, including transcranial direct-current stimulation (tDCS) [61] and electroconvulsive therapy (ECT) [62], or magnetic stimulation including magnetic seizure therapy (MST) [63] and repetitive transcranial magnetic stimulation (rTMS) [64…”
MethodNiwa, M., Nitta, A., Mizoguchi, H., Ito, Y., Noda, Y., Nagai, T., & Nabeshima, T. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.1575-07.2007 · Cited by 91 · cited 2×
“Shati/Nat8l was previously identified in the NAc of a mouse model of psychosis administered repeated methamphetamine treatment [140].”
BackgroundSelf-citationYang, B., Zhang, J.-C., Han, M., Yao, W., Yang, C., Ren, Q., Ma, M., Chen, Q.-X., & Hashimoto, K. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4399-2 · Cited by 91 · cited 1×
“Chronic stress decreases levels of BDNF and phosphorylated TrkB in the PFC, indicating the inactivation of TrkB signaling [76,77].”
BackgroundDong, E., Tueting, P. A., Matrisciano, F., Grayson, D. R., & Guidotti, A. (2016) · Translational Psychiatry · doi:10.1038/tp.2015.191 · Cited by 89 · cited 1×
“DNA methylation levels in the promoter region of BDNF also increased after stress exposure [160].”
BackgroundHistone Modifications in Aging: The Underlying Mechanisms and Implications
Wang, Y., Yuan, Q., & Xie, L. (2018) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x12666170817141921 · Cited by 89 · cited 1×
“Histone methylation and acetylation are generally considered to inhibit and activate gene transcription, respectively [156,157].”
BackgroundBDNF Release and Signaling Are Required for the Antidepressant Actions of GLYX-13
Kato, T., Fogaça, M. V., Deyama, S., Li, X.-Y., Fukumoto, K., & Duman, R. S. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.220 · Cited by 88 · cited 2×
“These findings are consistent with the results that microinfusion of BDNF into the PFC has antidepressant effects [81].”
BackgroundResultAbnormal Retinoid and TrkB Signaling in the Prefrontal Cortex in Mood Disorders
Qi, X., Zhao, J. Y., Liu, J., Fang, H., Swaab, D. F., & Zhou, J. (2013) · Cerebral Cortex · doi:10.1093/cercor/bht203 · Cited by 85 · cited 1×
“Clinical studies of postmortem brains have reported decreased BDNF and TrkB levels in the PFC of subjects who committed suicide [69,70] and patients with depression [71,72].”
BackgroundBzdega, T., Turi, T. G., Wróblewska, B., She, D., Chung, H. S., Kim, H., & Neale, J. H. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69062270.x · Cited by 84 · cited 1×
“NAAG is metabolized to NAA and glutamate by glutamate carboxypeptidase II (GCPII) [145], which are then metabolized to aspartate and acetylate and finally converted to acetyl-CoA by aspartoacylase (ASPA) [146].”
BackgroundInfluences of the Gut Microbiota on DNA Methylation and Histone Modification
Ye, J., Wu, W., Li, Y., & Li, L. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4538-6 · Cited by 84 · cited 1×
“Histone methylation and acetylation are generally considered to inhibit and activate gene transcription, respectively [156,157].”
BackgroundLearning relative values in the striatum induces violations of normative decision making
Klein, T. A., Ullsperger, M., & Jocham, G. (2017) · Nature Communications · doi:10.1038/ncomms16033 · Cited by 83
Xu, H., Wang, J., Zhang, K., Zhao, M., Ellenbroek, B. A., Shao, F., & Wang, W. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.11.013 · Cited by 79 · cited 1×
“Alterations in histone methylation in the promoter region of BDNF by stress were associated with depression-like behaviors in mice [159].”
BackgroundMeta-Analysis of BDNF Levels in Autism
Armeanu, R., Mökkönen, M., & Crespi, B. J. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-016-0415-7 · Cited by 75
Hippocampal volume and depression among young children
Barch, D. M., Tillman, R., Kelly, D., Whalen, D., Gilbert, K., & Luby, J. L. (2019) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2019.04.012 · Cited by 74 · cited 1×
“Structural alterations, including decreased hippocampal and PFC volumes, have been reported in patients with depression [99,100].”
BackgroundKang, S., Hong, S., Lee, J., Peyton, L., Baker, M. R., Choi, S. H., Kim, H. J., Chang, S.-Y., & Choi, D. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.04.023 · Cited by 74
Selective Serotonin Reuptake Inhibitor Exposure
Fitzgerald, K. T., & Bronstein, A. C. (2013) · Topics in companion animal medicine · doi:10.1053/j.tcam.2013.03.003 · Cited by 71 · cited 1×
“Consequently, tricyclic antidepressants have been developed to control the amount of serotonin in the brain [10].”
BackgroundDehn, L. B., & Beblo, T. (2019) · Neuropsychiatrie · doi:10.1007/s40211-019-0307-4 · Cited by 69 · cited 1×
“The symptoms of depression include deficits in cognitive function [4,5], loss of motivation [6], and anhedonia [7].”
BackgroundBorba, E. M., Duarte, J. A., Bristot, G., Scotton, E., Camozzato, A. L., & Chaves, M. L. F. (2016) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000450601 · Cited by 67
The importance of BDNF and RAGE in diabetes-induced dementia
Kim, O. Y., & Song, J. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105083 · Cited by 65
Molecular Characterization of N-Acetylaspartylglutamate Synthetase
Becker, I., Lodder, J., Gieselmann, V., & Eckhardt, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.111765 · Cited by 63 · cited 1×
“NAA is distributed at high concentrations in the CNS, and is biosynthesized to N-acetylaspartylglutamate (NAAG) by condensation with glutamic acid [142].”
BackgroundThe activation of BDNF reduced inflammation in a spinal cord injury model by TrkB/p38 MAPK signaling
Liang, J., Deng, G., & Huang, H. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.7109 · Cited by 63
Ma, M., Ren, Q., Yang, C., Zhang, J.-C., Yao, W., Dong, C., Ohgi, Y., Futamura, T., & Hashimoto, K. (2016) · Scientific Reports · doi:10.1038/srep39209 · Cited by 59 · cited 1×
“Decreased BDNF levels and reduced numbers and density of dendritic spines were observed in a mouse model of depression exposed to RSDS [103].”
BackgroundFukumoto, K., Fogaça, M. V., Liu, R.-J., Duman, C. H., Li, X., Chaki, S., & Duman, R. S. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0705-0 · Cited by 59 · cited 1×
“BDNF shows an antidepressant function in the PFC [54,55] and hippocampus [56,57] and a pro-depressant function in the BDNF in the mesolimbic dopamine (DA) circuit, originating in ventral tegmental area (VTA) DA neurons that project to the NAc [58].”
BackgroundSinghal, N. K., Huang, H., Li, S., Clements, R. J., Gadd, J., Daniels, A., Kooijman, E. E., Bannerman, P. G. C., Burns, T., Guo, F., et al. (2016) · Experimental Brain Research · doi:10.1007/s00221-016-4789-z · Cited by 58 · cited 2×
“NAAG is metabolized to NAA and glutamate by glutamate carboxypeptidase II (GCPII) [145], which are then metabolized to aspartate and acetylate and finally converted to acetyl-CoA by aspartoacylase (ASPA) [146].”
BackgroundJiang, N., Lv, J., Wang, H., Lü, C., Wang, Q., Xia, T., Bao, Y., Li, S., & Liu, X. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.09.007 · Cited by 58 · cited 1×
“BDNF shows an antidepressant function in the PFC [54,55] and hippocampus [56,57] and a pro-depressant function in the BDNF in the mesolimbic dopamine (DA) circuit, originating in ventral tegmental area (VTA) DA neurons that project to the NAc [58].”
BackgroundReynolds, L. M., & Reynolds, G. P. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.05.001 · Cited by 55 · cited 1×
“NAA levels are altered in the brains of patients with mental disorders, including depression, schizophrenia, and bipolar disorder [147].”
BackgroundInactivation of the putamen selectively impairs reward history-based action selection
Muranishi, M., Inokawa, H., Yamada, H., Ueda, Y., Matsumoto, N., Nakagawa, M., & Kimura, M. (2011) · Experimental Brain Research · doi:10.1007/s00221-011-2545-y · Cited by 54 · cited 1×
“Lesions in the dorsal striatum affect the establishment of habitual behaviors [130] and inactivation of the dorsal striatum weakens the reward system and induces goal-directed action even in the absence of a reward [131,132].”
BackgroundTaliaz, D., Nagaraj, V., Haramati, S., Chen, A., & Zangen, A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.07.025 · Cited by 54 · cited 4×
“Mesolimbic pathway Human [111] anti-depressant decreasing Animal [29,58,110,112,113,122]”
BackgroundInfluentialAnxiety in Parkinson's disease is associated with reduced structural covariance of the striatum
Oosterwijk, C. S., Vriend, C., Berendse, H. W., van der Werf, Y. D., & van den Heuvel, O. A. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.07.053 · Cited by 53 · cited 1×
“As the striatum-related circuit mechanisms underlying anxiety, the striatal-prefrontal pathway is involved and becomes less connected, the cortico-striatal connections are also impaired, and anxiety is expressed [134].”
BackgroundBowen, M. T., Dass, S. A. H., Booth, J., Suraev, A. S., Vyas, A., & McGregor, I. S. (2014) · Hormones and Behavior · doi:10.1016/j.yhbeh.2014.08.004 · Cited by 51
Cagni, F. C., Campêlo, C. L. D. C., Coimbra, D. G., Barbosa, M. R., Júnior, L. G. O., Neto, A. B. S., Ribeiro, A. M., Júnior, C. D. O. G., de Andrade, T. G., & Silva, R. H. (2016) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.16040062 · Cited by 51
Kramar, C. P., Loureiro, M., Renard, J., & Laviolette, S. R. (2017) · Cannabis and Cannabinoid Research · doi:10.1089/can.2016.0030 · Cited by 49 · cited 1×
“Recent studies have provided evidence of an association between the mesolimbic dopaminergic system and motivation- and mood-related behaviors, including social interaction [117,118].”
BackgroundJiang, N., Wang, H., Li, C., Zeng, G., Lv, J., Wang, Q., Chen, Y., & Liu, X. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113625 · Cited by 48 · cited 1×
“Neurogenesis in the hippocampus contributes to antidepressant effects [95,96].”
BackgroundKojima, M., & Mizui, T. (2017) · Vitamins and hormones · doi:10.1016/bs.vh.2016.11.006 · Cited by 47 · cited 1×
“BDNF also affects learning and memory, as well as neuronal survival, through the regulation of synaptic plasticity [36,37].”
BackgroundXu, H., Zhang, Y., Zhang, F., Yuan, S., Shao, F., & Wang, W. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00095 · Cited by 45 · cited 1×
“Chronic stress decreases levels of BDNF and phosphorylated TrkB in the PFC, indicating the inactivation of TrkB signaling [76,77].”
BackgroundInteraction between BDNF and TNF-α genes in schizophrenia
Zhang, Y., Fang, X., Fan, W., Tang, W., Cai, J., Song, L., & Zhang, C. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.12.024 · Cited by 43
Ketamine in Major Depressive Disorder: Mechanisms and Future Perspectives
Shin, C., & Kim, Y.-K. (2020) · Psychiatry Investigation · doi:10.30773/pi.2019.0236 · Cited by 42 · cited 1×
“However, long-term treatment safety requires consideration as ketamine has psychological side effects such as dissociation, psychotomimetics, and abuse potential [164].”
BackgroundAbsence of SHATI/Nat8l reduces social interaction in mice
Furukawa‐Hibi, Y., Nitta, A., Fukumitsu, H., Somiya, H., Toriumi, K., Furukawa, S., Nabeshima, T., & Yamada, K. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.08.028 · Cited by 39 · cited 1×
“This result supports the alteration of BDNF mRNA levels in some brain regions of genetic Shati/Nat8l KO mice [153].”
ResultSelf-citationTechnow, J. R., Hazel, N. A., Abela, J. R. Z., & Hankin, B. L. (2014) · Research on Child and Adolescent Psychopathology · doi:10.1007/s10802-014-9922-5 · Cited by 37
Melief, E. J., McKinley, J. W., Lam, J. Y., Whiteley, N. M., Gibson, A. W., Neumaier, J. F., Henschen, C. W., Palmiter, R. D., Bamford, N. S., & Darvas, M. (2018) · npj Parkinson s Disease · doi:10.1038/s41531-018-0060-6 · Cited by 33 · cited 1×
“The dorsal striatum is a part of the basal ganglia, which is important for the adjustment of the execution of motor habits [123]; thus, deficits in motor automaticity are a characteristic of basal ganglia-related illnesses, such as Parkinson’s disease [124].”
BackgroundLesion of striatal patches disrupts habitual behaviors and increases behavioral variability
Nadel, J. A., Neidhart, M., Pawelko, S. S., Copes‐Finke, D., & Howard, C. D. (2020) · PLoS ONE · doi:10.1371/journal.pone.0224715 · Cited by 32 · cited 1×
“Lesions in the dorsal striatum affect the establishment of habitual behaviors [130] and inactivation of the dorsal striatum weakens the reward system and induces goal-directed action even in the absence of a reward [131,132].”
BackgroundMiyamoto, Y., Iegaki, N., Fu, K., Ishikawa, Y., Sumi, K., Azuma, S., Uno, K., Muramatsu, S., & Nitta, A. (2017) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx078 · Cited by 31 · cited 3×
“Decreased serotonin levels were observed in the brains of STR-Shati OE mice [135].”
BackgroundInfluentialSelf-citationHaddar, M., Uno, K., Azuma, K., Muramatsu, S., & Nitta, A. (2019) · Addiction Biology · doi:10.1111/adb.12749 · Cited by 30 · cited 2×
“also showed attenuation of METH-induced conditioned place preference (CPP); however, locomotor activity was not changed [148,149].”
BackgroundSelf-citationDiniz, D. M., Calabrese, F., Brivio, P., Riva, M. A., Grandjean, J., & Homberg, J. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22095040 · Cited by 30
Miyanishi, H., Muramatsu, S., & Nitta, A. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01033-2 · Cited by 28 · cited 10×
“We also revealed that the expression levels of BDNF mRNA are correlated with social interaction behaviors [136].”
BackgroundInfluentialSelf-citationDipeptide Mimetics of Different NGF and BDNF Loops Activate PLC-γ1
Гудашева, Т. А., Логвинов, И. О., Николаев, С. В., Антипова, Т. А., Povarnina, P. Y., & Середенин, С. Б. (2020) · Doklady Biochemistry and Biophysics · doi:10.1134/s1607672920050075 · Cited by 26
Hardt, M., & Watson, A. H. D. (1999) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19990118)403:3<281::aid-cne1>3.0.co;2-0 · Cited by 25
Li, H., Wang, T., Shi, C., Yang, Y., Li, X., Wu, Y., & Xu, Q. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00588 · Cited by 25 · cited 1×
“BDNF shows an antidepressant function in the PFC [54,55] and hippocampus [56,57] and a pro-depressant function in the BDNF in the mesolimbic dopamine (DA) circuit, originating in ventral tegmental area (VTA) DA neurons that project to the NAc [58].”
BackgroundToriumi, K., Mamiya, T., Song, Z., Honjo, T., Watanabe, H., Tanaka, J., Kondo, M., Mouri, A., Kim, H., Nitta, A., et al. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.08.003 · Cited by 23 · cited 10×
“Elevation of NAA production via the upregulation of Shati/Nat8l after RSDS in susceptible mice, followed by an increase in acetyl-CoA, a substrate of histone acetylation, might cause enhanced H3K9acetylation.”
BackgroundInfluentialSelf-citationCosta, G., Serra, M., Marongiu, J., Morelli, M., & Simola, N. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109797 · Cited by 22 · cited 1×
“Many studies have shown that networks control the functions of emotional behaviors, motivation, and negative decision-making with other brain regions [133,154].”
BackgroundUno, K., Miyanishi, H., Sodeyama, K., Fujiwara, T., Miyazaki, T., Muramatsu, S., & Nitta, A. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112227 · Cited by 18 · cited 5×
“Furthermore, these mice also showed susceptibility to microdefeat stress [152].”
BackgroundResultInfluentialSelf-citationReduced striatal dopamine release during motor skill acquisition in Parkinson’s disease
Kawashima, S., Ueki, Y., Kato, T., Ito, K., & Matsukawa, N. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196661 · Cited by 17 · cited 1×
“The dorsal striatum is a part of the basal ganglia, which is important for the adjustment of the execution of motor habits [123]; thus, deficits in motor automaticity are a characteristic of basal ganglia-related illnesses, such as Parkinson’s disease [124].”
BackgroundHaddar, M., Uno, K., Hamatani, K., Muramatsu, S., & Nitta, A. (2019) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12068 · Cited by 12 · cited 2×
“also showed attenuation of METH-induced conditioned place preference (CPP); however, locomotor activity was not changed [148,149].”
BackgroundSelf-citationNitta, A., Noike, H., Sumi, K., Miyanishi, H., Tanaka, T., Takaoka, K., Nagakura, M., Iegaki, N., Kaji, J.-I., Miyamoto, Y., et al. (2018) · Springer eBooks · doi:10.1007/978-981-10-8488-1_6 · Cited by 10 · cited 1×
“In the novel object test, the HIP-Shati OE mice preferred to approach the novel object in the trial session compared with control mock mice [150].”
BackgroundSelf-citationMiyanishi, H., Uno, K., Iwata, M., Kikuchi, Y., Yamamori, H., Yasuda, Y., Ohi, K., Hashimoto, R., Hattori, K., Yoshida, S., et al. (2020) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b19-01099 · Cited by 7 · cited 1×
“A previous human study showed that Shati/Nat8l was a diagnostic biomarker for depression [151].”
MethodSelf-citationHappiness and Treatment Outcome in Resistant Depression
Papakostas, G. I. (2020) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.20com13636 · Cited by 3 · cited 1×
“Considering the loss of happiness and motivation as the main symptoms in patients with depression [119], it is quite likely that abnormalities of the mesolimbic DA system are involved in depressive-like outcomes [58,120].”
BackgroundGholaminejad, A., Pourbadie, H. G., Nasehi, M., & Naghdi, N. (2019) · PubMed Central · doi:10.22037/ijpr.2019.1100745 · Cited by 1 · cited 1×
“The PFC plays an important role in learning, memory, and decision-making processes [59,60].”
Background
Cited by
Jemni, M., Zaman, R., Carrick, F. R., Clarke, N. D., Marina, M., Bottoms, L. M., Matharoo, J. S., Ramsbottom, R., Hoffman, N., Groves, S. J., et al. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1102526 · Cited by 93
“…that BDNF plays a major role in major depressive disorder (MDD) that BDNF-knockout mice are widely used to examine the experimental role of other markers, inflammatory responses, and gene expression in MDD animal models (Jodeiri Farshbaf & Alviña, 2021; Miyanishi & Nitta, 2021; Li et al., 2022).”
BackgroundProbiotics for the treatment of depression and its comorbidities: A systemic review
Gao, J., Zhao, N., Cheng, Y., Lei, W., Wang, Y., Liu, X., Zheng, N., Shao, L., Chen, X., Sun, Y., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1167116 · Cited by 87
“Thus, novel antidepressant agents and strategies are required (Miyanishi and Nitta, 2021).”
BackgroundFlavonols in Action: Targeting Oxidative Stress and Neuroinflammation in Major Depressive Disorder
Jembrek, M. J., Oršolić, N., Karlović, D., & Peitl, V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24086888 · Cited by 63
Pardossi, S., Fagiolini, A., & Cuomo, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313098 · Cited by 51
“Alterations in BDNF levels have been implicated in the pathogenesis of MDD, with evidence suggesting that reduced BDNF expression in key brain regions, such as the hippocampus and prefrontal cortex, may contribute to the development of depressive symptoms [4,5].”
Liaqat, H., Parveen, A., & Kim, S. Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314968 · Cited by 53
Metadata
- Authors
- Miyanishi, H., & Nitta, A.
- Affiliations
- University of Toyama (JP)
- Corresponding author
- Nitta, Atsumi
- ORCID
- Nitta, Atsumi
- Venue
- Pharmaceuticals
- Publisher
- MDPI AG
- Published
- 2021-09-01
- Volume
- 14
- Issue
- 9
- Pages
- 889
- ISSN
- 1424-8247 (ISSN-L)
- PMC
- PMC8469819
- OpenAlex
- W3197234894
- Cited by
- 57
- References
- 164
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 26 · 2023: 9 · 2022: 9
- FWCI
- 1.39
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Pharmaceuticals (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Japan Society for the Promotion of Science (21H02632, 16H06276)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Keywords
- brain-derived neurotrophic factor, depression, dorsal striatum, N-acetyltransferase, epigenetic regulation, social stress, stress sensitivity, antidepressant targets, depression vulnerability, prefrontal cortex, hippocampus, nucleus accumbens
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.